Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse

FEBS Journal

Volumn 274, Issue 6, 2007, Pages 1492-1502

  Kuczius, Thorsten ^a   Grassi, Jacques ^b   Karch, Helge ^a   Groschup, Martin H ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Institut National de la Recherche Agronomique   (France)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Antibody; Glycotyping; Prion protein; PrPC; Signal intensity

Indexed keywords

PRION PROTEIN; PROTEINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATTLE; CELL DIFFERENTIATION; GLYCOSYLATION; HUMAN; IMMUNOBLOTTING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHEEP;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CATTLE; GLYCOSYLATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PHENOTYPE; PRPC PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SHEEP;

BOS; BOVINAE; MUS; OVIS ARIES;

EID: 33847361034     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05691.x     Document Type: Article

References (50)

1. Collinge J, Sidle KC, Meads J, Ironside J & Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690.
2. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501.
3. Prusiner SB (1991) Molecular biology of prion diseases. Science 252, 1515-1522.
4. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90, 10962-10966.
5. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino A, Borchelt DR, Teplow D, Hood L, Burlingame A et al. (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274, 1-13.
6. Kuczius T & Groschup MH (1999) Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med 5, 406-418.
7. Groschup MH, Kuczius T, Junghans F, Sweeney T, Bodemer W & Buschmann A (2000) Characterization of BSE and scrapie strains/isolates. Arch Virol Suppl 16, 217-226.
8. Gambetti P, Kong Q, Zou W, Parchi P & Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66, 213-239.
9. Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, Ironside JW & Collinge J (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126, 1333-1346.
10. Sc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279, 16797-16804.
11. Chen SG & Gambetti P (2002) A journey through the species barrier. Neuron 34, 854-856.
12. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT Jr & Caughey B (1995) Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci USA 92, 3923-3927.
13. Oesch B, Westaway D & Prusiner SB (1991) Prion protein genes: evolutionary and functional aspects. Curr Top Microbiol Immunol 172, 109-124.
14. Wopfner F, Weidenhofer G, Schneider R, von Brunn A, Gilch S, Schwarz TF, Werner T & Schatzl HM (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 289, 1163-1178.
15. Bendheim PE, Brown HR, Rudelli RD, Scala LJ, Goller NL, Wen GY, Kascsak RJ, Cashman NR & Bolton DC (1992) Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42, 149-156.
16. Kretzschmar HA, Prusiner SB, Stowring LE & DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122, 1-5.
17. Stahl N, Baldwin MA, Burlingame AL & Prusiner SB (1990) Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochem 29, 8879-8884.
18. Caughey B (1993) Scrapie associated PrP accumulation and its prevention: insights from cell culture. Br Med Bull 49, 860-872.
19. c. Br Med Bull 66, 61-70.
20. Maglio LE, Perez MF, Martins VR, Brentani RR & Ramirez OA (2004) Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 131, 58-64.
21. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM & Kellermann O (2000) Signal transduction through prion protein. Science 289, 1925-1928.
22. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W et al. (1997) The cellular prion protein binds copper in vivo. Nature 390, 684-687.
23. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P & Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270, 19173-19780.
24. Shyng SL, Huber MT & Harris DA (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268, 15922-15928.
25. Jimenez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B & Prelli F (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153, 1561-1572.
26. c in mammalian brain: interspecies variation and location in membrane rafts. Biol Chem 387, 297-300.
27. Nieznanski K, Rutkowski M, Dominik M & Stepkowski D (2005) Proteolytic processing and glycosylation influence formation of porcine prion protein complexes. Biochem J 387, 93-100.
28. Zhao H, Klingeborn M, Simonsson M & Linne T (2006) Proteolytic cleavage and shedding of the bovine prion protein in two cell culture systems. Virus Res 115, 43-55.
29. Beringue V, Mallinson G, Kaisar M, Tayebi M, Sattar Z, Jackson G, Anstee D, Collinge J & Hawke S (2003) Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain 126, 2065-2073.
30. Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA & Bratberg B (2003) Cases of scrapie with unusual features in Norway and designation of a new type Nor98. Vet Rec 153, 202-208.
31. Buschmann A, Biacabe AG, Ziegler U, Bencsik A, Madec JY, Erhardt G, Luhken G, Baron T & Groschup MH (2004) Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. J Virol Meth 117, 27-36.
32. Gretzschel A, Buschmann A, Eiden M, Ziegler U, Luhken G, Erhardt G & Groschup MH (2005) Strain typing of German transmissible spongiform encephalopathies field cases in small ruminants by biochemical methods. J Vet Med B Infect Dis Vet Public Health 52, 55-63.
33. Kuczius T, Haist I & Groschup MH (1998) Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. J Infect Dis 178, 693-699.
34. Lezmi S, Martin S, Simon S, Comoy E, Bencsik A, Deslys JP, Grassi J, Jeffrey M & Baron T (2004) Comparative molecular analysis of the abnormal prion protein in field scrapie cases and experimental bovine spongiform encephalopathy in sheep by use of western blotting and immunohistochemical methods. J Virol 78, 3654-3662.
35. Sweeney T, Kuczius T, McElroy M, Gomez Parada M & Groschup MH (2000) Molecular analysis of Irish sheep scrapie cases. J General Virol 81, 1621-1627.
36. Sc from scrapie. Biochem Biophys Res Commun 328, 1024-1027.
37. Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head MW et al. (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97, 10168-10172.
38. Moya KL, Sales N, Hassig R, Creminon C, Grassi J & Di Giamberardino L (2000) Immunolocalization of the cellular prion protein in normal brain. Microsc Res Tech 50, 58-65.
39. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK & Yee VC (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8, 770-774.
40. Liu A, Riek R, Zahn R, Hornemann S, Glockshuber R & Wuthrich K (1999) Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy. Biopolymers 51, 145-152.
41. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, Billeter M, Calzolai L, Wider G & Wuthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97, 145-150.
42. Demart S, Fournier JG, Creminon C, Frobert Y, Lamoury F, Marce D, Lasmezas C, Dormont D, Grassi J & Deslys JP (1999) New insight into abnormal prion protein using monoclonal antibodies. Biochem Biophys Res Commun 265, 652-657.
43. Morel N, Simon S, Frobert Y, Volland H, Mourton-Gilles C, Negro A, Sorgato MC, Creminon C & Grassi J (2004) Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrils. J Biol Chem 279, 30143-30149.
44. Sc)-specific epitope defined by a monoclonal antibody. Nature 390, 74-77.
45. Krasemann S, Groschup M, Hunsmann G & Bodemer W (1996) Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice. J Immunol Methods 199, 109-118.
46. Krasemann S, Jurgens T & Bodemer W (1999) Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy. J Biotechnol 73, 119-129.
47. Harmeyer S, Pfaff E & Groschup MH (1998) Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J General Virol 79, 937-945.
48. Thuring CM, Erkens JH, Jacobs JG, Bossers A, van Keulen LJ, Garssen GJ, van Zijderveld FG, Ryder SJ, Groschup MH, Sweeney T et al. (2004) Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein. J Clin Microbiol 42, 972-980.
49. Kuczius T, Buschmann A, Zhang W, Karch H, Becker K, Peters G & Groschup MH (2004) Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding. Biol Chem 385, 739-747.
50. Feraudet C, Morel N, Simon S, Volland H, Frobert Y, Creminon C, Vilette D, Lehmann S & Grassi J (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 280, 11247-11258.